On the other hand, FBI Washington Field Office Acting Assistant Director in Charge James Dawson commented, “Today’s charges, the latest in a series of law enforcement actions taken against large drug companies, confirm that this kind of criminal behavior in the generic pharmaceutical industry will not be tolerated.”
“Price fixing and bid rigging is a crime, and the American people—who rely on these drugs to treat serious ailments—are the ones who pay the price when companies like Teva conspire to raise their costs. The FBI remains committed to holding companies accountable for their illegal and reprehensible activity,” added Dawson.
Teva “firmly rejects” the DOJ’s allegations
In response to the charges, Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) expressed its disappointment with the federal government’s decision to prosecute the matter.
According to the American Israeli pharmaceutical company, it has been conducting its own investigation into the allegations for more than four years and concluded that it was not involved in price-fixing.
